{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:14Z","timestamp":1788872294207,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K000500\/1"],"award-info":[{"award-number":["MR\/K000500\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K008749\/1"],"award-info":[{"award-number":["MR\/K008749\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K011987\/1"],"award-info":[{"award-number":["MR\/K011987\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["082813"],"award-info":[{"award-number":["082813"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["093010\/Z\/10\/Z"],"award-info":[{"award-number":["093010\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.pt.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T15:47:05Z","timestamp":1366213625000},"page":"207-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich's vision of chemotherapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Sam","family":"Alsford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2013.03.004_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2013.03.004_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management of trypanosomiasis and leishmaniasis","volume":"104","author":"Barrett","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.pt.2013.03.004_bib0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox\u2013eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, Phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2013.03.004_bib0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.2.2746.353","article-title":"Address in pathology, on chemiotherapy. Delivered before the Seventeenth International Congress of Medicine","volume":"2","author":"Ehrlich","year":"1913","journal-title":"Br. Med. J."},{"key":"10.1016\/j.pt.2013.03.004_bib0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pt.2013.03.004_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-4758(94)90393-X","article-title":"Invariant surface proteins in bloodstream forms of Trypanosoma brucei","volume":"10","author":"Overath","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2013.03.004_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.1156296","article-title":"A haptoglobin\u2013hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans","volume":"320","author":"Vanhollebeke","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pt.2013.03.004_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0025727300057045","article-title":"Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept","volume":"47","author":"Prull","year":"2003","journal-title":"Med. Hist."},{"key":"10.1016\/j.pt.2013.03.004_bib0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2958.2010.07156.x","article-title":"The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill","volume":"76","author":"Vanhollebeke","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2013.03.004_bib0050","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/S0021-9258(18)83720-6","article-title":"Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein","volume":"264","author":"Hajduk","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2013.03.004_bib0055","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.75.7.3450","article-title":"Identification of the trypanocidal factor in normal human serum: high density lipoprotein","volume":"75","author":"Rifkin","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/IAI.67.4.1910-1916.1999","article-title":"Characterization of a novel trypanosome lytic factor from human serum","volume":"67","author":"Raper","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2013.03.004_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0166-6851(95)00019-W","article-title":"High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum","volume":"70","author":"Tomlinson","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pt.2013.03.004_bib0080","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1073\/pnas.0609902104","article-title":"Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum","volume":"104","author":"Vanhollebeke","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.03.004_bib0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4161\/viru.3.1.18295","article-title":"Haptoglobin\u2013hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors","volume":"3","author":"Bullard","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.pt.2013.03.004_bib0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","article-title":"A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense","volume":"95","author":"Xong","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/EC.05112-11","article-title":"Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity","volume":"10","author":"Stephens","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pt.2013.03.004_bib0105","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1073\/pnas.1214943110","article-title":"Structure of the trypanosome haptoglobin\u2013hemoglobin receptor and implications for nutrient uptake and innate immunity","volume":"110","author":"Higgins","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.03.004_bib0110","doi-asserted-by":"crossref","first-page":"e1728","DOI":"10.1371\/journal.pntd.0001728","article-title":"Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance","volume":"6","author":"Symula","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2013.03.004_bib0115","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1073\/pnas.1007074107","article-title":"Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor","volume":"107","author":"Kieft","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2013.03.004_bib0120","doi-asserted-by":"crossref","first-page":"e1287","DOI":"10.1371\/journal.pntd.0001287","article-title":"Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1","volume":"5","author":"Capewell","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2013.03.004_bib0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pt.2013.03.004_bib0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nm1395","article-title":"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor","volume":"12","author":"Baral","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2013.03.004_bib0135","doi-asserted-by":"crossref","first-page":"e1000685","DOI":"10.1371\/journal.ppat.1000685","article-title":"C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense","volume":"5","author":"Lecordier","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2013.03.004_bib0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.pt.2012.09.002","article-title":"Trypanosome resistance to human innate immunity: targeting Achilles\u2019 heel","volume":"28","author":"Stephens","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0145","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1017\/S0031182010001137","article-title":"Chemotherapy against human African trypanosomiasis: is there a road to success?","volume":"137","author":"Burri","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2013.03.004_bib0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(93)90096-T","article-title":"The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action","volume":"54","author":"Vansterkenburg","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2013.03.004_bib0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-6851(02)00096-8","article-title":"Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei","volume":"122","author":"Pal","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0160","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jcs.079178","article-title":"Rab28 function in trypanosomes: interactions with retromer and ESCRT pathways","volume":"124","author":"Lumb","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pt.2013.03.004_bib0165","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2958.2008.06195.x","article-title":"The LAMP-like protein p67 plays an essential role in the lysosome of African trypanosomes","volume":"68","author":"Peck","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2013.03.004_bib0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/EC.00273-12","article-title":"Evidence for recycling of invariant surface transmembrane domain proteins in African trypanosomes","volume":"12","author":"Koumandou","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0175","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1600-0854.2008.00797.x","article-title":"Evolution of the multivesicular body ESCRT machinery; retention across the eukaryotic lineage","volume":"9","author":"Leung","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.pt.2013.03.004_bib0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/EC.05012-11","article-title":"Ubiquitylation and developmental regulation of invariant surface protein expression in trypanosomes","volume":"10","author":"Leung","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2007.08.046","article-title":"Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes","volume":"131","author":"Engstler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gr.115089.110","article-title":"High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome","volume":"21","author":"Alsford","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.pt.2013.03.004_bib0195","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1242\/jcs.081596","article-title":"Evolutionary reconstruction of the retromer complex and its function in Trypanosoma brucei","volume":"124","author":"Koumandou","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pt.2013.03.004_bib0200","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.ejca.2008.09.026","article-title":"Targeted therapies in breast cancer: where are we now?","volume":"44","author":"Di Cosimo","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.pt.2013.03.004_bib0205","doi-asserted-by":"crossref","first-page":"31232","DOI":"10.1074\/jbc.M110.212613","article-title":"The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site","volume":"286","author":"Morgan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2013.03.004_bib0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.mib.2012.05.006","article-title":"Therapeutic targets and recent advances in protein immunotoxins","volume":"15","author":"Madhumathi","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.pt.2013.03.004_bib0215","doi-asserted-by":"crossref","first-page":"e1002072","DOI":"10.1371\/journal.ppat.1002072","article-title":"High affinity nanobodies against the Trypanosoma brucei VSG are potent trypanolytic agents that block endocytosis","volume":"7","author":"Stijlemans","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2013.03.004_bib0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molbiopara.2010.11.004","article-title":"The VSG C-terminal domain is inaccessible to antibodies on live trypanosomes","volume":"175","author":"Schwede","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0225","doi-asserted-by":"crossref","first-page":"54887","DOI":"10.1074\/jbc.M409311200","article-title":"Cytoplasmic targeting signals in transmembrane invariant surface glycoproteins of trypanosomes","volume":"279","author":"Chung","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2013.03.004_bib0230","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrmicro2221","article-title":"The trypanosome flagellar pocket","volume":"7","author":"Field","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2013.03.004_bib0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-6851(01)00332-2","article-title":"Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy","volume":"117","author":"Matovu","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0240","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1093\/emboj\/cdf474","article-title":"Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library","volume":"21","author":"Morris","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.pt.2013.03.004_bib0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molbiopara.2007.07.020","article-title":"Dileucine signal-dependent and AP-1-independent targeting of a lysosomal glycoprotein in Trypanosoma brucei","volume":"156","author":"Allen","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2013.03.004_bib0255","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nsmb.1829","article-title":"A plasma-membrane E-MAP reveals links of the eisosome with sphingolipid metabolism and endosomal trafficking","volume":"17","author":"Aguilar","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.pt.2013.03.004_bib0260","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1091\/mbc.e12-05-0375","article-title":"Sbf\/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling","volume":"23","author":"Jean","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0265","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/EC.00156-09","article-title":"Role of AP-1 in developmentally regulated lysosomal trafficking in Trypanosoma brucei","volume":"8","author":"Tazeh","year":"2009","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.pt.2013.03.004_bib0270","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1242\/jcs.112.18.3061","article-title":"Characterization of tGLP-1, a Golgi and lysosome-associated, transmembrane glycoprotein of African trypanosomes","volume":"112","author":"Lingnau","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pt.2013.03.004_bib0275","doi-asserted-by":"crossref","first-page":"49117","DOI":"10.1074\/jbc.M105962200","article-title":"A novel C-terminal kinesin is essential for maintaining functional acidocalcisomes in Trypanosoma brucei","volume":"276","author":"Dutoya","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2013.03.004_bib0280","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/emboj\/cdg481","article-title":"Clathrin-mediated endocytosis is essential in Trypanosoma brucei","volume":"22","author":"Allen","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.pt.2013.03.004_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1937-6448(09)78001-3","article-title":"Macromolecular trafficking and immune evasion in African trypanosomes","volume":"278","author":"Field","year":"2009","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.pt.2013.03.004_bib0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/bj20030469","article-title":"Rab5 and Rab11 mediate transferrin and anti-variant surface glycoprotein antibody recycling in Trypanosoma brucei","volume":"374","author":"Pal","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.pt.2013.03.004_bib0295","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1600-0854.2008.00785.x","article-title":"Ubiquitylation is required for degradation of transmembrane surface proteins in trypanosomes","volume":"9","author":"Chung","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.pt.2013.03.004_bib0300","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149221300038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149221300038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:31:37Z","timestamp":1761463897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149221300038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S147149221300038X"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2013.03.004","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich's vision of chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}